| Similar Articles |
|---|
 |
The Motley Fool
May 20, 2004
Tom Taulli |
Cardinal Rules of M&A Cardinal Health is upbeat on its latest acquisition, but needs bigger deals to push growth.   |
The Motley Fool
April 7, 2011
Brandon Glenn |
"Generic Wave" to Drive Cardinal Health's Profitability in Coming Years The generic wave could mean big money for Cardinal and top competitors. |
The Motley Fool
January 18, 2005
Brian Gorman |
Cardinal Doesn't Get Ruffled The drug distributor's potential loss of Japanese pharmaceutical Eisai will hurt in the short term, but fortunately for investors Cardinal Health continues to plan wisely. |
The Motley Fool
January 30, 2006
Brian Gorman |
Cardinal Inches Higher The distribution is looking healthier, but Cardinal Health still has work to do. Investors, take note. |
The Motley Fool
June 27, 2011
Brandon Glenn |
Cardinal Health Products Won't Be in Cleveland Medical Mart (or Any Other) Once an early high-profile supporter of the medical mart concept, drug distributor Cardinal Health has had an apparent change of opinion. |
The Motley Fool
June 28, 2005
Brian Gorman |
Cardinal Changes Course The health care company's warning is a disappointment, but the firm's new focus on returning cash to shareholders is far from bad news. |
BusinessWeek
November 24, 2003
Roger O. Crockett |
Cardinal Health, Heal Thyself CEO Walter aims to revive growth, selling high-tech gear and expanding overseas. |
The Motley Fool
August 3, 2006
Ryan Fuhrmann |
Cardinal Distributes the Goods The drug wholesaler and distributor has to regain investor confidence and rebuild a track record in a changed industry. So far, so good for 2006. Let's see if any further information can be found once Cardinal submits its 10-K filing to the SEC. |
The Motley Fool
June 13, 2006
Ryan Fuhrmann |
Cardinal Looks to Deliver Cardinal Health has been through a tumultuous couple of years but appears to have weathered company-specific and industry storms. If the drug distributor can meet its long-term goals, then its stock should represent a long-term solid investment. |
The Motley Fool
December 10, 2004
Brian Gorman |
Cardinal Picks a Lilly Cardinal Health's deal with Lilly suggests the new fee-for-service model is gaining traction. |
The Motley Fool
September 9, 2011
Brandon Glenn |
Cardinal Health Looks to PET Drugs to Drive Margins The nuclear medicine business is an important driver of higher margins for the drug distribution company. |
The Motley Fool
October 28, 2004
Brian Gorman |
Cardinal's Good News: No News The drug wholesaler took a major step toward rehabilitating itself with the release of its 10-K. |
The Motley Fool
January 26, 2007
Billy Fisher |
A Clean Bill of Health at Cardinal Good results and a key divestiture have this health care company rolling. Investors, take note. |
The Motley Fool
November 7, 2007
Billy Fisher |
Cardinal Has Its Wings Clipped Despite a healthy year-over-year pop of 15% in EPS from operations, much of the focus in the first-quarter was shifted to a weak performance by Cardinal's pharmaceutical services segment. |
The Motley Fool
October 26, 2005
Stephen D. Simpson |
Cardinal's Tweet More Sweet Changes at the giant manufacturer, distributor, and service provider in the health-care industry are working out well, but the stock price already reflects it. |
The Motley Fool
January 21, 2005
Rich Duprey |
Cardinal Back in the Nest Drug distributor and Japanese pharma Eisai come to agreement after all. |
The Motley Fool
March 23, 2011
Jordan DiPietro |
Should You Buy and Hold Cardinal Health? Does this company have the traits of a good retirement stock? |
The Motley Fool
August 24, 2011
Brandon Glenn |
Cardinal Health Sees Opportunity (but Faces Challenges) in Specialty Drugs Is Cardinal up for the challenge? |
The Motley Fool
August 5, 2005
Stephen D. Simpson |
Can This Cardinal Sing? If Cardinal Health succeeds in its plans to return more capital to shareholders, this could become an interesting income play. This stock is worth keeping an eye on for the future. |
The Motley Fool
July 28, 2004
Brian Gorman |
Cardinal Watching Cardinal Health continues to be pummeled, but wait patiently, because a buying opportunity could emerge. |
The Motley Fool
May 2, 2008
Steven Renaldi |
Cardinal Health Gets Its Nest in Order Share price rises as investors hope the company is beginning to put some of its troubles behind it. |
BusinessWeek
August 30, 2004
Gene G. Marcial |
PSS Is Really Delivering The Goods When David Smith took the CEO job at PSS World Medical in 2000, sales stood at $160 million. They've since rocketed to $1.35 billion. No wonder industry giants are eyeballing the company: They hope Smith will sell. |
The Motley Fool
September 2, 2009
Brian Orelli |
Should You Buy This Spinoff? Cardinal Health kicks its baby out of the nest. |
The Motley Fool
February 5, 2008
Will Frankenhoff |
3 Reasons to Stay in Chinese Stocks in 2008 The recent savage sell-off in Chinese stocks -- the Shanghai index has fallen more than 13% since the beginning of the year -- may represent a buying opportunity. |
The Motley Fool
September 30, 2008
Brian Orelli |
Cardinal Health Clips Its Wings Does it make sense for the drug wholesaler to spin off its medical equipment business? |
Chemistry World
March 3, 2015
Phillip Broadwith |
J&J to sell cardiac devices to wholesaler Cardinal Johnson & Johnson has agreed to sell its cardiovascular surgical devices subsidiary, Cordis, to wholesale supplier Cardinal Health. |
The Motley Fool
October 6, 2008
Brian Orelli |
Cardinal Atones for Its Sins The drugmaker gets its licenses to distribute controlled substances reinstated. |
The Motley Fool
May 12, 2008
Bill Mann |
The World's Greatest Value Finally, the price is right to invest in China, the top international market. |
The Motley Fool
July 1, 2004
W.D. Crotty |
Drug Wholesalers Taking a Beating A sharp drop at drug wholesaler Cardinal Health provides a unique buying opportunity. |
The Motley Fool
February 9, 2007
Will Frankenhoff |
I Love Chinese Stocks Given the overall strength of the Chinese economy and the attractive valuations of many "red-chip" companies, investors should consider opening their hearts to this emerging market's potential rewards, and adding to their positions during any weakness. |
Entrepreneur
May 2005
Mark Henricks |
Eastern Influence Chinese companies are becoming increasingly active in buying, merging with and doing joint ventures with smaller U.S companies -- usually in search of technology. |
On Wall Street
February 1, 2012
Dave Lindorff |
Finding the Safe Bet in China "Things are amazing in China," exclaims an enthusiastic Sean Lynch, global investment strategist for Wells Fargo Private Bank. |
Search Engine Watch
May 4, 2011
Andy Atkins-Kruger |
Should Google Escape the Death Spiral in China by 'Losing Face'? Weighing which of four paths Google should take when it comes to China: promote within China but remain in Hong Kong; do something completely different; re-enter China; or do nothing. |
The Motley Fool
May 6, 2008
Steven Renaldi |
McKesson Garners Generic Growth New products offer the generic-drug distributor profit potential in a competitive industry. |
The Motley Fool
July 21, 2011
Tim Hanson |
How Chinese Investors Invest in China Interestingly, little-to-no fraud has been exposed at Chinese public companies trading in China. This could be a solution to staying away from the Chinese market. |
Entrepreneur
January 2008
Chris Penttila |
Can You Compete? Chinese manufacturers aren't just making your stuff - they're making their own, too. |
The Motley Fool
May 2, 2005
Brian Gorman |
Cardinal Health Perks Up The drug distribution company is working through its problems, which should make for a brighter fiscal 2006. Investors, take note. |
The Motley Fool
June 20, 2008
Colleen Paulson |
China Goes Power Shopping Shop for stocks with Chinese growth potential. |
